Microsoft Research unveiled Project Quine, a multimodal AI world model for biology developed with Harvard and the Broad Institute. It integrates genomics, proteins, and imaging to accelerate drug discovery by pre-screening molecules and optimizing lab resources. Tested on pancreatic cancer cell lines, it identified novel phenotypic shifts in one weekend, potentially saving years and millions. Microsoft launched the Quine Fellows program for early access. The system is strictly for research, requiring manual review, and will not be used in clinical settings.